主页文献库搜索
Leveraging Real-World Data From a Clinicogenomic Database Addresses the Treat...

Ciniselli(CM),Conca(E),Bartoletti(M),Colom... JCO Precis Oncol 2025-09-00

...BRCA1 (11.7%) and BRCA2 (6.5%) variants, CGP revealed further potentially actionable alterations (amplifications and/or ...

Homologous Recombination Proficiency in High-Grade Serous Epithelial Ovarian ...

Pavanello(M),Vieira(CM),Arenhardt(MP),Nogu... Curr Issues Mol Biol 2025-09-01

...BRCA1/2 reversion mutations, demethylation of BRCA1 and RAD51C). We also discuss controversial topics regarding HRP tumo...

The increasing burden of early-onset pancreatic and biliary tract cancers: a ...

Boilève(A),Brugel(M),Rémond(M),Valéry(M),D... ESMO Gastrointest Oncol 2025-09-00

...BRCA1/2, CDKN2A, and mismatch repair gene mutations, contribute to familial clustering, while other nonhereditary risk f...

DNA Methylation in Ovarian and Endometrial Cancers: Predictive and Mechanisti...

Kitamura(S),Taguchi(A),Tamai(K),Yamamoto(Y... Cancer Sci 2025-11-00

...BRCA1 promoter methylation in homologous recombination-deficient ovarian cancers or MLH1 promoter methylation in deficie...

Risk of melanoma among people with BRCA1 and BRCA2 pathogenic variants: A sys...

Frontera(NM),Ahsan(MD),Chandler(IR),Levi(S... Gynecol Oncol 2025-10-00

...BRCA1/2 PGV was 2.8 (95 % CI 1.5-5.4), with similar ORs for BRCA1 (3.2 [95 % CI 1.6-6.3]) and BRCA2 (2.8 [95 % CI 1.2-6....

Chromosomal instability and genomic alterations in cholangiocarcinoma from No...

Deenonpoe(R),Guscott(MA),Watcharadetwittay... J Pathol 2025-11-00

...BRCA1. This study provides increased understanding of the rate and potential mechanisms of CIN in CCA that may inform ne...

Clinical pharmacology and therapeutic applications of talazoparib: a comprehe...

Pasupulati(SL),Srinivasa Rao(K),Sharma(S),... Cancer Chemother Pharmacol 2025-09-16

...BRCA1/2 breast malignancies and for local castration-resistant prostate cancer (when combined with enzalutamide) due to ...

Development of a Synthetic Lethality-Based Combination Therapy Using LIG1 and...

Tani(M),Hatano(K),Ishizuya(Y),Oka(T),Kanak... Cancer Sci 2025-12-00

...BRCA1/2 mutations, due to resistance. Thus, identifying novel synthetic lethal interactions with PARP may expand treatme...

BARD1: A Friend or Foe in Pancreatic Ductal Adenocarcinoma?

Zekavat(L),Jain(A) Int J Mol Sci 2025-09-17

...BRCA1-Associated RING Domain 1) plays a complex role in tumor biology, functioning either as a tumor suppressor or as an...

Domain-Specific DNA Binding Activities of BRCA1 Reveal Substrate Preferences ...

Lowran(K),Campbell(L),Cismas(E),Wu(CG) Biochemistry 2025-09-16

BRCA1 is a crucial component of homologous recombination (HR), a high-fidelity pathway for repairing double-stranded DNA...

上一页 107 108 109 110 111 112 113 114 115 下一页 111 / 共 1000

联系地址

山东省济南市章丘区文博路2号

齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号

大学科技园北区F座4单元2楼

电话: 0531-88819269

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。


商务邮箱

E-mail: product@genelibs.com